
Metergo 0.125mg Tablet
Marketer
Lupin Ltd
Salt Composition
Methylergometrine (0.125mg)
Overview Metergo 0.125mg Tablet
Uterine bleeding following childbirth or termination of pregnancy may be managed with the medication Metergo 0.125mg Tablet. This medication enhances uterine muscle tone, contraction frequency, and strength, thereby minimizing postpartum hemorrhage. Metergo 0.125mg Tablets may be ingested with or without food; however, consistent timing optimizes therapeutic efficacy. Dosage and frequency are determined by your physician based on your individual needs and condition. Follow your doctor's instructions precisely. Swallow the tablet whole with water. Continue treatment for the duration prescribed. Common adverse effects include headache, elevated blood pressure, and convulsions. Report any concerning or severe side effects to your doctor; mitigation strategies may be available. Alcohol consumption is generally discouraged during treatment. Inform your physician of any pre-existing heart conditions or hypertension before commencing treatment. Furthermore, disclose all other medications you are currently using, as interactions may compromise efficacy or alter the drug's effects.
Uses of Metergo 0.125mg Tablet
Hemorrhage postpartum
Major Benefits of Metergo 0.125mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metergo 0.125mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Metergo 0.125mg Tablet:
- High blood pressure
- Headache
- Seizure
How to use Metergo 0.125mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 0.125mg Metergo tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Metergo 0.125mg Tablet works:
Each 0.125mg Metergo tablet contains an ergot alkaloid that induces prolonged uterine smooth muscle contractions. This vascular constriction effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Metergo 0.125mg Tablet may pose unknown risks. Physician consultation is advised.
PregnancyUNSAFE
The use of Metergo 0.125mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician, as research in both animal and human subjects indicates substantial risks to fetal development.
Breast feedingCAUTION
The administration of Metergo 0.125mg tablets necessitates prudence while breastfeeding. Nursing should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Metergo 0.125mg Tablet on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Metergo 0.125mg Tablet use in individuals with impaired renal function is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of 0.125mg Metergo tablets to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Metergo 0.125mg Tablet :
Should you forget to take your Metergo 0.125mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Metergo 0.125mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Action Class | Drugs inducing uterine contractions |
